---
title: "Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM) — Share Price, Financials & Analysis"
symbol: "JAGSNPHARM"
company: "Jagsonpal Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/JAGSNPHARM"
isin: "INE048B01035"
nse_symbol: "JAGSNPHARM"
bse_code: "507789"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 1522.71
generated_at: "2026-09-13T19:10:12.679Z"
---

# Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM)

Canonical page: https://tapetide.com/stocks/JAGSNPHARM

## Company

- **NSE Symbol:** JAGSNPHARM
- **BSE Code:** 507789
- **ISIN:** INE048B01035
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2000-03-01
- **CEO:** Mr. Manish Gupta
- **Employees:** 1399
- **Face Value:** ₹2
- **F&O Eligible:** No
- **Website:** jagsonpal.com

## About

Incorporated in 1978, Jagsonpal Pharmaceuticals Ltd manufactures and trades pharmaceutical products and active pharmaceutical ingredients[1]

## Latest Price

- **Price:** ₹232.89
- **Change:** -0.1 (-0.04%)
- **Open:** ₹229.21
- **Day High:** ₹234.6
- **Day Low:** ₹228.01
- **Previous Close:** ₹232.99
- **Volume:** 51421
- **As Of:** 2026-09-11T09:59:55+00:00

## Key Fundamentals

Observed at 2026-09-11T04:48:03.051677Z.

- **Market Cap:** ₹1522.71 Cr
- **Classification:** Microcap
- **P/E (reported):** 33.8
- **P/E (TTM):** 34.05
- **EPS (TTM):** ₹6.84
- **EPS (reported):** ₹8.61
- **Book Value:** ₹41.84
- **Price to Book:** 5.56
- **Dividend Yield:** 1.72%
- **ROE:** 23.07%
- **ROCE:** 28.06%
- **Debt to Equity:** 0.03
- **Revenue (yearly):** ₹287.23 Cr
- **Net Income:** ₹44.33 Cr
- **EBITDA:** ₹56 Cr
- **52-Week High:** ₹264.5
- **52-Week Low:** ₹155
- **RSI (14):** 46.42

## Tapetide Score

- **Score:** 63 / 100
- **Score date:** 2026-09-04
- **Archetype:** Quality at a Reasonable Price
- **What it means:** Financial strength is not being paid for with a demanding multiple. The question worth asking is whether the quality is durable or reflects a good patch — check the consistency of returns over several years rather than the latest quarter.
- **Pillar profile:** Quality: Good · Valuation: Fair · Momentum: Rising
- **Percentile:** 94.2 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 90.39 | 9% |
| growth | 19.07 | 9% |
| momentum | 67.71 | 12% |
| ownership | 70.28 | 24% |
| quality | 72.48 | 22% |
| valuation | 51.38 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 50.3%
- Promoter holding has increased by 1.17% over last quarter.
- Company's working capital requirements have reduced from 24.0 days to 11.0 days

### Weaknesses

- The company has delivered a poor sales growth of 8.85% over past five years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 57.24% | 18.52% | 95.96% |
| ebitda margin growth | 40.56% | -12.57% | 26.08% | 45.38% |
| net income growth | 50% | -19.98% | 16% | 21% |
| revenue growth | 26.26% | 3.73% | 7% | 9% |
| roce | — | 81.03% | 33.37% | 20.46% |
| roe | — | 92.41% | 17.29% | 64.9% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 58 | 47 | 43 | 61 | 75 | 74 | 59 | 76 | 74 | 73 | 64 | 82 |
| Expenses | 49 | 44 | 41 | 51 | 58 | 58 | 50 | 61 | 58 | 57 | 53 | 65 |
| Operating Profit | 8 | 3 | 3 | 10 | 16 | 16 | 9 | 14 | 16 | 16 | 11 | 17 |
| OPM % | 14 | 7 | 6 | 17 | 22 | 21 | 15 | 19 | 22 | 22 | 17 | 21 |
| Other Income | 2 | 3 | 2 | -2 | 2 | 26 | 3 | 3 | 3 | 1 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 10 | 5 | 5 | 7 | 15 | 39 | 9 | 14 | 17 | 15 | 12 | 18 |
| Tax % | 25 | 25 | 22 | 25 | 25 | 17 | 24 | 25 | 25 | 25 | 25 | 25 |
| Net Profit | 7 | 4 | 4 | 5 | 11 | 32 | 7 | 11 | 13 | 11 | 9 | 13 |
| EPS in Rs | 1.14 | 0.6 | 0.54 | 0.81 | 1.73 | 4.82 | 0.99 | 1.62 | 1.89 | 1.64 | 1.31 | 2 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 127 | 167 | 159 | 188 | 218 | 237 | 209 | 269 | 287 | 294 |
| Expenses | 138 | 157 | 150 | 169 | 192 | 203 | 186 | 218 | 229 | 233 |
| Operating Profit | -11 | 9 | 9 | 19 | 26 | 34 | 23 | 51 | 58 | 61 |
| OPM % | -9 | 6 | 5 | 10 | 12 | 14 | 11 | 19 | 20 | 21 |
| Other Income | 0 | 1 | 3 | 4 | 3 | 2 | 9 | 28 | 10 | 10 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 2 | 1 | 2 | 8 | 9 | 9 |
| Profit before tax | -12 | 9 | 9 | 22 | 27 | 35 | 30 | 70 | 58 | 61 |
| Tax % | -1 | 20 | 16 | 22 | 29 | 23 | 25 | 21 | 25 | — |
| Net Profit | -12 | 7 | 8 | 17 | 19 | 27 | 22 | 55 | 43 | 45 |
| EPS in Rs | -1.76 | 1.1 | 1.2 | 2.6 | 2.88 | 4.08 | 3.4 | 8.34 | 6.43 | 6.84 |
| Dividend Payout % | -2 | 9 | 17 | 15 | 56 | 49 | 59 | 30 | 62 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 |
| Reserves | 97 | 85 | 91 | 98 | 109 | 120 | 146 | 174 | 227 | 263 |
| Borrowings | 8 | 8 | 4 | 5 | 7 | 0 | 6 | 9 | 9 | 8 |
| Other Liabilities | 25 | 23 | 28 | 31 | 35 | 31 | 30 | 21 | 29 | 32 |
| Total Liabilities | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |
| Fixed Assets | 22 | 21 | 22 | 22 | 26 | 23 | 24 | 9 | 94 | 85 |
| CWIP | 0 | 3 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 11 | 15 | 51 | 1 | 0 | 0 | 0 |
| Other Assets | 121 | 105 | 110 | 109 | 123 | 91 | 170 | 208 | 184 | 231 |
| Total Assets | 143 | 130 | 136 | 147 | 164 | 164 | 195 | 217 | 278 | 317 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -3 | -2 | 31 | 11 | 28 | 7 | 47 | 35 | 55 | 47 |
| Cash from Investing Activity | 41 | -3 | -1 | -11 | -2 | -26 | -58 | -25 | -45 | -36 |
| Cash from Financing Activity | -34 | -1 | -6 | -1 | -7 | -18 | 0 | -9 | -12 | -12 |
| Net Cash Flow | 5 | -6 | 24 | 0 | 19 | -36 | -11 | 2 | -2 | -1 |
| Free Cash Flow | 40 | -5 | 30 | 12 | 28 | 6 | 48 | 35 | 90 | 47 |
| CFO/OP | -6 | 14 | 311 | 150 | 164 | 54 | 158 | 189 | 124 | 101 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 100 | 73 | 45 | 49 | 25 | 26 | 32 | 19 | 18 | 22 |
| Inventory Days | 295 | 307 | 164 | 191 | 134 | 122 | 82 | 68 | 58 | 51 |
| Days Payable | 56 | 54 | 59 | 76 | 82 | 76 | 66 | 35 | 37 | 40 |
| Cash Conversion Cycle | 339 | 325 | 150 | 164 | 77 | 72 | 48 | 53 | 39 | 33 |
| Working Capital Days | 154 | 149 | 67 | 55 | 32 | 59 | 34 | 52 | 9 | 11 |
| ROCE % | 3 | -10 | 9 | 9 | 18 | 20 | 25 | 17 | 23 | 23 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 68.71% | 68.48% | 68.09% | 68.04% | 67.97% | 67.81% | 67.78% | 67.65% | 67.54% | 67.39% | 67.89% | 69.05% |
| FIIs | 0.38% | 0% | 0.73% | 1.1% | 2.3% | 2.1% | 2.1% | 2.18% | 2.12% | 2.12% | 2.44% | 2.3% |
| DIIs | 0.83% | 0% | 0.85% | 0.85% | 0.11% | 0% | 0% | 0.05% | 0.09% | 0.15% | 0.22% | 0.62% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 21.99% | 21.94% | 20.69% | 20.79% | 20.38% | 20.64% | 20.94% | 24.26% | 21.13% | 21.2% | 20.73% | 19.33% |
| Others | 8.09% | 9.58% | 9.64% | 9.22% | 9.24% | 9.45% | 9.17% | 5.86% | 9.12% | 9.14% | 8.71% | 8.7% |
| No. of Shareholders | 16041 | 15785 | 16282 | 15748 | 15633 | 18471 | 21085 | 22899 | 24653 | 24895 | 26264 | 24824 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Buy
- **Buy / Neutral / Sell:** 8 / 5 / 6

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 238.06 | Sell |
| EMA (10) | 236.57 | Sell |
| SMA (20) | 237.27 | Sell |
| EMA (20) | 236.29 | Sell |
| SMA (50) | 232.56 | Buy |
| EMA (50) | 231.5 | Buy |
| SMA (100) | 221.91 | Buy |
| EMA (100) | 222.96 | Buy |
| SMA (200) | 203.8 | Buy |
| EMA (200) | 216.36 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.3 | Neutral |
| MACD (12,26,9) | 1.13 | Sell |
| Stochastic (14,3,3) | 24.32 | Neutral |
| ADX (14) | 36.65 | Buy |
| Williams %R (14) | -77.37 | Neutral |
| ATR (14) | 8.29 | High Volatility |
| ROC (12) | -3.84 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 43.61 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9c77f861-5204-4338-80ea-5be203560f0d.pdf) |
| 2026-08-27 | [Announcement Under Regulation 30-SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bc167d8-4869-4a75-93fc-f829c953e9ef.pdf) |
| 2026-08-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37d49935-bedc-40ba-9852-1834935f2a98.pdf) |
| 2026-08-27 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4f89176-7675-4695-971a-8cc905702942.pdf) |
| 2026-08-27 | [Notice Of 47Th Annual General Meeting And Annual Report For The FY 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d64dfaf-0cf9-470b-986f-2b154c8eca10.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f7f4afd-95ab-44b0-986c-e18fff80ec28.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7999d1f-4f22-4850-9539-0dfdaf60d4a7.pdf) |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1291c71-c93f-4e57-a9b3-ad50c3fb28bd.pdf) |
| 2026-07-29 | [Board Meeting Outcome for Outcome Of Board Meeting Held On July 29 2026 Along With Unaudited (Standalone) Financial Results For The Quarter June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71c5fe43-efb8-4b32-907f-db5033bc97db.pdf) |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4473cf0-a8ea-4b5c-8c83-4e6df9c83212.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb55d5c9-b500-4d84-8c5e-a27eee9d3369.pdf) |
| 2026-05-04 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=721f1437-9b61-4f9f-ab4f-e10de53e812a.pdf) |
| 2026-01-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34b1a767-1439-465b-924c-69b545d3a86b.pdf) |
| 2025-11-07 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=344040a4-306a-4bdd-a0cd-5345a0ea1795.pdf) |
| 2025-07-31 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ab02c33-adcb-4c3e-b4c8-ec9f0a89a8d2.pdf) |
| 2025-05-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f538ec5d-ba34-4c69-aec7-b824b9c0c2f1.pdf) |
| 2025-01-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f4a76e6-5cad-436f-b67c-b10c9dbb5a0c.pdf) |
| 2024-10-29 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef3c1c32-5168-43ec-a8ad-37e66505d06e.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-07-30 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a5d8974-bb22-4d09-96be-960f39fa89f3.pdf) |
| 2026-04-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6e785f8-b2a9-446c-9f7a-aa6ad0b7b67c.pdf) |
| 2026-01-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=493a7558-6ba4-4844-ac7d-e4c1be128755.pdf) |
| 2025-11-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c50c5c-8567-451f-8344-fb186300c3a4.pdf) |
| 2025-07-28 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e11c785d-3fbf-4e18-898f-4c393bea1cf6.pdf) |
| 2025-05-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=728b8896-d5e5-4fb3-9d6f-1d6732731aba.pdf) |
| 2024-10-24 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de34dddc-f426-4706-94f4-98fc667977ec.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-07-29 | [Unaudited Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ced908f7-8e48-4d48-8f94-7d44224c3872.pdf) |
| 2026-04-27 | [Audited Financial Results For The Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=992ddc14-22ac-4106-9bfb-3e98ead37beb.pdf) |
| 2026-01-21 | [Outcome Of Board Meeting Held On January 21 2026 Along With Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab3a9cd6-ad17-4e78-85c8-d56f4e664a8e.pdf) |
| 2025-11-03 | [Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d93ae0a-c6fc-4dd9-88fb-76b017a19a39.pdf) |
| 2025-07-26 | [Results- Financial Results For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79a7aa7c-fb7f-47ff-8789-df4854540e9c.pdf) |
| 2025-05-06 | [Audited (Standalone) Financial Results For The Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76e0e5f4-4cad-43a8-81af-056319590215.pdf) |
| 2025-01-22 | [Outcome Of Board Meeting Held On January 22 2025 To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d2729cf2-4565-4f88-9237-7bacd28ad3c6.pdf) |
| 2024-10-23 | [Outcome Of Board Meeting Held On October 23, 2024 & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements Regulations, 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4c54404-69e7-4445-9d65-05db0dcc99c9.pdf) |
| 2024-08-07 | [Outcome Of Board Meeting Held On August 07, 2024 Along With Unaudited Financial Results For The Quarter Ended June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6d655ca-cea3-446d-b15f-bdb3e8dd3dd6.pdf) |
| 2024-05-20 | [Outcome Of Board Meeting Held On May 20, 2024 Along With Audited (Standalone) Financial Results For The Quarter And Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c06ece6-e90f-48a3-857d-d24f6f163c29.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-07-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1a47187-f788-452c-bae9-a6e92de71f0b.pdf) |
| 2026-04-27 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=814a3eea-5587-4212-852c-f29aa857c6ec.pdf) |
| 2026-01-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50f29d76-4e8a-446b-a571-60c71bae4969.pdf) |
| 2025-11-03 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69192bd4-c5b6-4b1f-810e-6e723d9822a9.pdf) |
| 2025-07-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3721c27-a575-4b08-b2cf-52809821b11e.pdf) |
| 2025-07-26 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a28bb2c3-a0a4-47c5-80f0-ce2bf8f80577.pdf) |
| 2025-05-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ae9ac29-12b4-46d4-a15e-11d759f2c5b4.pdf) |
| 2024-10-24 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad92753b-e936-412c-86ed-a52086eaf606.pdf) |
| 2022-02-21 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4123fe62-8c6c-4e7a-b81f-92ff5d923e63.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Mar - Grant of 1,152,500 ESOPs at Rs.139 each; vesting in four annual tranches from March 9, 2027. | [Announcement Under Regulation 30 Of SEBI LODR 9 Mar - Grant of 1,152,500 ESOPs at Rs.139 each; vesting in four annual tranches from March 9, 2027.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8aaab5ee-6699-401e-bfc1-0e68f0495d82.pdf) |
| 9 Mar - Board meeting on March 12, 2026 to consider buyback of Rs.2 face-value equity shares. | [Board Meeting Intimation for Proposal Of Buyback Of Equity Shares Of The Company 9 Mar - Board meeting on March 12, 2026 to consider buyback of Rs.2 face-value equity shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/91ad34bd-ffc3-4735-90ac-d72b7da8e158.pdf) |
| 7h - Press Release for Audited Results for the quarter and year ended March 31, 2026 | [Announcement under Regulation 30 (LODR)-Investor Presentation 7h - Press Release for Audited Results for the quarter and year ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/814a3eea-5587-4212-852c-f29aa857c6ec.pdf) |
| 7 May - Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company | [Announcement under Regulation 30 (LODR)-Newspaper Publication 7 May - Newspaper Publication regarding dispatch of Letter of Offer of Buy Back to the shareholders of the Company](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a710fbda-5592-4fef-910f-b85c70d6fd84.pdf) |
| 6h - Record date fixed for buyback of 16,00,000 shares at ₹250 each, up to ₹40 crore. | [Intimation Of Record Date For The Purpose Of Buy-Back Of Up To 16,00,000 Fully Paid-Up Equity Shares Of Face Value ?2/- Each At A Price Of ?250/- Per Share, For An Aggregate Amount Not Exceeding ?40 Crores 6h - Record date fixed for buyback of 16,00,000 shares at ₹250 each, up to ₹40 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/0f745d6f-8139-461e-8deb-d2d26f8d7bbd.pdf) |
| 6 May - Jagsonpal launches 16 lakh share buyback at ₹250 each, totaling up to ₹40 crore; opens May 8, 2026. | [Submission Of Letter Of Offer For Buy-Back Upto 16,00,000 Equity Shares 6 May - Jagsonpal launches 16 lakh share buyback at ₹250 each, totaling up to ₹40 crore; opens May 8, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/fbe40126-d006-4d06-9853-70b2c7e45845.pdf) |
| 4 May - Earning Call Transcript for meeting held on April 28, 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 May - Earning Call Transcript for meeting held on April 28, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/721f1437-9b61-4f9f-ab4f-e10de53e812a.pdf) |
| 4 May - Earning Call Transcript for meeting held on April 28, 2026 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 May - Earning Call Transcript for meeting held on April 28, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/721f1437-9b61-4f9f-ab4f-e10de53e812a.pdf) |
| 2d - Allotment of 71,800 Equity shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 2d - Allotment of 71,800 Equity shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022](https://www.bseindia.com/xml-data/corpfiling/AttachLive/2a7a91b4-83e7-4296-8357-e3858438aff6.pdf) |
| 29 Apr - Submission of Public Announcement pertaining to Buy back of Shares of Company published in the newspaper along with Board and Shareholder Resolution | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Submission of Public Announcement pertaining to Buy back of Shares of Company published in the newspaper along with Board and Shareholder Resolution](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8e76dd4f-36e7-42f2-8d2e-4b481020ab3e.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9e1f4937-9ec7-4d1a-909d-0e0619688217.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9e1f4937-9ec7-4d1a-909d-0e0619688217.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ef3c1c32-5168-43ec-a8ad-37e66505d06e.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/69192bd4-c5b6-4b1f-810e-6e723d9822a9.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/344040a4-306a-4bdd-a0cd-5345a0ea1795.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fad6cf0b-5bbf-443b-b811-a627b68cf181.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fad6cf0b-5bbf-443b-b811-a627b68cf181.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2107e0a7-cba9-4622-aaa0-e5ebdabac017.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2107e0a7-cba9-4622-aaa0-e5ebdabac017.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ae9ac29-12b4-46d4-a15e-11d759f2c5b4.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/371f75ec-1941-4204-a584-ce609fd2510f.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/72fbf11b-8ab2-43aa-8ef6-f35f6b95754d.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4d304879-4a29-4b8b-a351-f98be75d3820.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/507789/74571507789.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/507789/71817507789.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/507789/66074507789.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/507789/5077890319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/507789/5077890318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:10:12.679Z.